NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/31/2022
Back to search
Official data from USPTO
ABLBIO MEDICINE FOR A BETTER LIFE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
36
Latest update
04/21/2023
Trademark type
Combined
Nice classes
5
Filing date
01/31/2020
Registration date
05/31/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/31/2022
Last transaction
04/21/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
Drawing code
5
Owner type
03
Owner location
Gyeonggi-do, KR
Examiner
ROSEN, BENJAMIN
Law office
N20
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the letters "ABLBIO" in which "ABL" is in black letters and "BIO" is in yellow-orange letters, beneath which is the phrase "MEDICINE FOR A BETTER LIFE" in which the letters "A", "B", and "L" are in red and the remainder are in black.
Holders and representatives
Holders
ABL Bio, Inc.
Representatives
Steven J. Hultquist HULTQUIST, PLLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
ophthalmic preparations; ophthalmologic preparations; biopharmaceutical preparations for the treatment of cancer; biological preparations for the treatment of cancer; pharmaceutical preparations for the treatment of cancer; biological preparations for medical or veterinary purposes for the treatment and prevention of cancersneurodegenerative diseasesinfectious diseases; diagnostic reagents for medical or veterinary purposes; biotechnological pharmaceutical preparations for medical purposes for the treatment and prevention of cancersneurodegenerative diseasesinfectious diseases; biological preparations for medical purposes for the treatment and prevention of cancersneurodegenerative diseasesinfectious diseases; antibodies being biological preparations for medical purposes for the treatment and prevention of cancersneurodegenerative diseasesinfectious diseases; pharmaceutical preparations for the treatment of tumors; pharmaceutical preparations for use in oncology; pharmaceutical preparations for the treatment of central nervous system diseases; pharmaceutical preparations acting on the central nervous system; diagnostic biomarker reagents for medical purposes; pharmaceutical preparations for the treatment of Parkinson's disease; anti-cancer preparations; tumor suppressing agents
Publications
History of USPTO decisions and trademark events.
36 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
05/31/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/15/2022
PUBO
PUBLISHED FOR OPPOSITION
03/15/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/23/2022
ADBS
1(B) BASIS DELETED; NEW BASIS REQUESTED
02/04/2022
IUCN
NOTICE OF ALLOWANCE CANCELLED
02/03/2022
ATRQ
ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED
12/28/2021
PCBG
PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
12/28/2021
APET
ASSIGNED TO PETITION STAFF
12/28/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/07/2021
EX1G
SOU EXTENSION 1 GRANTED
12/05/2021
EXT1
SOU EXTENSION 1 FILED
12/05/2021
EEXT
SOU TEAS EXTENSION RECEIVED
12/05/2021
TPAD
TEAS PETITION TO AMEND BASIS RECEIVED
12/05/2021
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
06/15/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/20/2021
PUBO
PUBLISHED FOR OPPOSITION
04/20/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/31/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/13/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/12/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/12/2021
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
03/12/2021
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
10/07/2020
GNFR
FINAL REFUSAL E-MAILED
10/07/2020
CNFR
FINAL REFUSAL WRITTEN
10/07/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/16/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/16/2020
ALIE
ASSIGNED TO LIE
09/15/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/20/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/21/2020
GNRT
NON-FINAL ACTION E-MAILED
04/21/2020
CNRT
NON-FINAL ACTION WRITTEN
04/21/2020
DOCK
ASSIGNED TO EXAMINER
04/21/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/05/2020
NWAP
NEW APPLICATION ENTERED
02/04/2020
Continuous trademark protection
Get notified about every new filing that threatens ABLBIO MEDICINE FOR A BETTER LIFE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.